GCP
CPIX icon

GSA Capital Partners’s Cumberland Pharmaceuticals CPIX Stock Holding History

GSA Capital Partners’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,326
Closed -$60K – 1757
2016
Q1 		$60K Sell
13,326
-2,600
-16% -$12.4K ﹤0.01% 1610
2015
Q4 		$84K Buy
15,926
+2,454
+18% +$14K ﹤0.01% 1750
2015
Q3 		$78K Sell
13,472
-42,828
-76% -$267K ﹤0.01% 1671
2015
Q2 		$403K Buy
56,300
+32,099
+133% +$223K 0.02% 1469
2015
Q1 		$161K Sell
24,201
-34,767
-59% -$217K 0.01% 1964
2014
Q4 		$354K Hold
58,968
– – 0.02% 1168
2014
Q3 		$291K Sell
58,968
-2,550
-4% -$12.3K 0.02% 1280
2014
Q2 		$277K Sell
61,518
-432
-0.7% -$1.93K 0.01% 1455
2014
Q1 		$279K Buy
61,950
+6,255
+11% +$29.8K 0.02% 1181
2013
Q4 		$285K Buy
55,695
+5,300
+11% +$25.9K 0.02% 1238
2013
Q3 		$228K Sell
50,395
-5,900
-10% -$29.4K 0.02% 1317
2013
Q2 		$288K Buy
+56,295
New +$280K 0.03% 892

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

GSA Capital Partners's CPIX Position: Q2 2016 in Review

GSA Capital Partners sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2016, closing a stake of 13,326 shares — an estimated $60K sold.

GSA Capital Partners first reported a position in CPIX in Q2 2013 and held it in 12 quarters. The position peaked at $403K in Q2 2015. 44 funds tracked by Wall St. Rank hold CPIX as of Q2 2016.

  • GSA Capital Partners reported no remaining Cumberland Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • GSA Capital Partners sold 13,326 Cumberland Pharmaceuticals shares in Q2 2016, an estimated $60K.
  • GSA Capital Partners first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • GSA Capital Partners's Cumberland Pharmaceuticals position peaked at $403K in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2016.

Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.